United States · FDA National Drug Code directory
PROMACTA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0972_b8a1cc48-9aaf-486a-9305-090acccb5c02
- Product NDC
- 0078-0972
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- eltrombopag olamine
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180927
- Source listing expiry
- 20261231
Source-listed ingredients
- ELTROMBOPAG OLAMINE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTON in 1 KIT (0078-0972-61) / 30 PACKET in 1 CARTON (0078-0972-23) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0972-19) · 0078-0972-61
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →